General data-analysis tools:cCemical Diversity (RMI)
通用数据分析工具:cChemical Diversity (RMI)
基本信息
- 批准号:7032046
- 负责人:
- 金额:$ 38.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-23 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): We propose to create a flexible but comprehensive software environment for quantitative chemical biology research. A primary goal of this environment will be to aid chemists in synthetic planning, and biologists in interpreting screening results and selecting molecules, using concepts and tools familiar to these researchers. By designing software with these researchers in mind, we will provide both novel analytical processes and access to critical tools that have previously been accessible only to computational scientists. Simultaneously, by building tight collaborations between chemical biologists, computational scientists, statisticians, and software architects, we will provide higher-end functionality and interoperability with other software and data sources that more sophisticated users will ultimately demand. Our proposed information model and software environment will allow experimental scientists to work within the same conceptual framework as their computational counterparts, bridging critical gaps between theory and experiment, and applying the strengths of each approach to common problems. Easy-to-use software for diversity analysis, synthetic reagent selection, and determination of structural features relevant to measured outcomes, will place important decision-making tools into the hands of the research community, and be especially useful for chemists synthesizing molecules, and biologists selecting molecules, pursuant to the goals of the NIH Road Map Molecular Libraries Initiative (MLI).
We have assembled a multidisciplinary team that is uniquely qualified to provide such software for three reasons. First, we have considerable experience in the field of experimental chemical genetics, including planning, synthesis, and relating chemical structure to biological outcomes. Second, we have experience developing web-enabled software for both chemistry and bioinformatics. Third, we reside within a rich intellectual environment (The Broad Institute of Harvard and MIT) that is a center of excellence in bioinformatics and genomic medicine, and that will provide access during software development to a wealth of experimental design strategies and data analysis methods. By deploying key software tools to experimentalists, we will,develop practical use-cases and interface requirements that will guide further development of software central to present and future NIH Road Map MLI activities. A primary goal of our effort will be to integrate new tools for chemistry and chemical biology with existing analysis tools for genomic medicine, expanding the reach of chemistry tools to enable bioinformatics and clinical researchers to have increasing impact on public health.
描述(由申请人提供):我们建议为定量化学生物学研究创建一个灵活但全面的软件环境。该环境的主要目标是帮助化学家进行合成规划,并帮助生物学家使用这些研究人员熟悉的概念和工具解释筛选结果和选择分子。通过设计软件,考虑到这些研究人员,我们将提供新的分析过程和访问以前只有计算科学家才能访问的关键工具。与此同时,通过在化学生物学家、计算科学家、统计学家和软件架构师之间建立紧密合作,我们将提供更高端的功能以及与其他软件和数据源的互操作性,以满足更复杂的用户最终的需求。 我们提出的信息模型和软件环境将允许实验科学家在与计算同行相同的概念框架内工作,弥合理论和实验之间的关键差距,并将每种方法的优势应用于常见问题。易于使用的多样性分析,合成试剂的选择,并确定相关的测量结果的结构特征的软件,将重要的决策工具到研究界的手中,并特别有用的化学家合成分子,和生物学家选择分子,根据NIH路线图分子图书馆倡议(MLI)的目标。
我们组建了一个多学科团队,该团队具有提供此类软件的独特资格,原因有三。首先,我们在实验化学遗传学领域拥有丰富的经验,包括规划,合成,以及将化学结构与生物结果联系起来。第二,我们有开发网络支持的化学和生物信息学软件的经验。第三,我们居住在一个丰富的知识环境(哈佛和麻省理工学院的布罗德研究所),这是一个卓越的中心,在生物信息学和基因组医学,并将提供访问在软件开发过程中,以丰富的实验设计策略和数据分析方法。通过向实验者部署关键软件工具,我们将开发实际用例和接口要求,这些用例和接口要求将指导软件的进一步开发,这些软件对当前和未来的NIH路线图MLI活动至关重要。我们努力的主要目标是将化学和化学生物学的新工具与现有的基因组医学分析工具相结合,扩大化学工具的范围,使生物信息学和临床研究人员能够对公共卫生产生越来越大的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL ANDREW CLEMONS其他文献
PAUL ANDREW CLEMONS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL ANDREW CLEMONS', 18)}}的其他基金
Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues
使用分子胶从 CTD^2 网络转化新的癌症靶点和机制
- 批准号:
10704124 - 财政年份:2022
- 资助金额:
$ 38.9万 - 项目类别:
Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues
使用分子胶从 CTD^2 网络转化新的癌症靶点和机制
- 批准号:
10505307 - 财政年份:2022
- 资助金额:
$ 38.9万 - 项目类别:
A Translator Knowledge Provider for Systems Chemical Biology
系统化学生物学翻译知识提供者
- 批准号:
10332543 - 财政年份:2020
- 资助金额:
$ 38.9万 - 项目类别:
A Translator Knowledge Provider for Systems Chemical Biology
系统化学生物学翻译知识提供者
- 批准号:
10548044 - 财政年份:2020
- 资助金额:
$ 38.9万 - 项目类别:
Biomedical Data Translator Technical Feasibility Assessment and Architecture Design
生物医学数据转换器技术可行性评估和架构设计
- 批准号:
9540181 - 财政年份:2016
- 资助金额:
$ 38.9万 - 项目类别:
Informing synthetic decision making using cheminformatic and bioinformatic profil
使用化学信息学和生物信息学分析为综合决策提供信息
- 批准号:
7696771 - 财政年份:2008
- 资助金额:
$ 38.9万 - 项目类别:
General data-analysis tools to relate chemical diversity
关联化学多样性的通用数据分析工具
- 批准号:
7125582 - 财政年份:2005
- 资助金额:
$ 38.9万 - 项目类别:
General data-analysis tools to relate chemical diversity
关联化学多样性的通用数据分析工具
- 批准号:
7476648 - 财政年份:2005
- 资助金额:
$ 38.9万 - 项目类别:
Small-molecule fluorophores: screening for specific protein or RNA binding
小分子荧光团:筛选特定蛋白质或 RNA 结合
- 批准号:
6941848 - 财政年份:2004
- 资助金额:
$ 38.9万 - 项目类别:
Informing synthetic decision making using cheminformatic and bioinformatic profil
使用化学信息学和生物信息学分析为综合决策提供信息
- 批准号:
8331513 - 财政年份:
- 资助金额:
$ 38.9万 - 项目类别:
相似海外基金
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
靶向端粒酶逆转录酶 (TERT) 的突变启动子
- 批准号:
10677899 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Developing a nucleic acid force field with direct chemical perception for computational modeling of nucleic acid therapeutics
开发具有直接化学感知的核酸力场,用于核酸治疗的计算建模
- 批准号:
10678562 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease
发现用于治疗阿尔茨海默病的磷脂酶 C-gamma2 变构激活剂
- 批准号:
10901007 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Proto-OKN Theme 1: BioBricks-OKG An Open Knowledge Graph For Cheminformatics And Chemical Safety
Proto-OKN 主题 1:BioBricks-OKG 化学信息学和化学品安全的开放知识图
- 批准号:
2333728 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Cooperative Agreement
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
- 批准号:
10749251 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Cheminformatics and Machine Learning approaches for GPCR Computer Aided Drug Design
GPCR 计算机辅助药物设计的化学信息学和机器学习方法
- 批准号:
BB/X511778/1 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Training Grant
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
鉴定用于乳腺癌治疗的核酸外切酶 1 小分子抑制剂
- 批准号:
10735307 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections
针对必要目标重新设计现有药物 (ReEDIT) 平台技术,用于发现治疗真菌感染的新药
- 批准号:
10600245 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
EnzyDock-based Multistate and Multiscale Tools for Covalent Drug Design
基于 EnzyDock 的多状态和多尺度共价药物设计工具
- 批准号:
10575904 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别:
Dual Fatty Acid Amide Hydrolase (FAAH)/Monoacylglycerol lipase (MAGL) Inhibitors for Cannabis Use Disorder (CUD).
双脂肪酸酰胺水解酶 (FAAH)/单酰基甘油脂肪酶 (MAGL) 抑制剂,用于治疗大麻使用障碍 (CUD)。
- 批准号:
10577008 - 财政年份:2023
- 资助金额:
$ 38.9万 - 项目类别: